The Type 1 Diabetes Genetics Consortium (T1DGC).
Onengut-Gumuscu S. et al, (2025), J Clin Endocrinol Metab
Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry.
Ellis MJ. et al, (2024), Acta neuropathologica, 147
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
Marcovecchio ML. et al, (2024), Diabetologia
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells
Inaba A. et al, (2023), Nature Communications, 14
SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile
Zhang J-Y. et al, (2023), Genome Medicine, 15
Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis
Kwok AJ. et al, (2023), Nature Immunology, 24, 767 - 779
Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes
Zhang J-Y. et al, (2022), Nature Communications, 13
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage.
Sioofy-Khojine A-B. et al, (2022), Diabetologia
Single-cell multi-omics analysis reveals IFN-driven alterations in T lymphocytes and natural killer cells in systemic lupus erythematosus
Trzupek D. et al, (2022), Wellcome Open Research, 6, 149 - 149
Childhood body size directly increases type 1 diabetes risk based on a lifecourse Mendelian randomization approach.
Richardson TG. et al, (2022), Nature communications, 13
An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci.
Mountjoy E. et al, (2021), Nat Genet, 53, 1527 - 1533
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
Downes DJ. et al, (2021), Nature Genetics, 53, 1606 - 1615
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Robertson CC. et al, (2021), Nature genetics
Single-cell multi-omics analysis reveals IFN-driven alterations in T lymphocytes and natural killer cells in systemic lupus erythematosus
Trzupek D. et al, (2021), Wellcome Open Research, 6, 149 - 149
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Collier DA. et al, (2021), Nature, 593, 136 - 141
Analysis of overlapping genetic association in type 1 and type 2 diabetes.
Inshaw JRJ. et al, (2021), Diabetologia
In vivo negative regulation of SARS-CoV-2 receptor, ACE2, by interferons and its genetic control
Ansari MA. et al, (2021), Wellcome Open Research, 6, 47 - 47
Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics.
Ghoussaini M. et al, (2021), Nucleic acids research, 49, D1311 - D1320
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells
Arroyo Hornero R. et al, (2020), Communications Biology, 3